{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:37:11Z","timestamp":1772152631193,"version":"3.50.1"},"reference-count":46,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Measles and rubella are vaccine-preventable viral diseases and can be prevented by safe, highly effective vaccination with measles- and rubella-containing vaccines. Given the myriad causes of febrile exanthems, laboratory surveillance for both measles and rubella is important to document the incidence of these diseases and to track the progress and maintenance of elimination in near- and post-elimination settings. Diagnostic challenges can hinder effective surveillance and classification challenges can hinder efforts to demonstrate achievement or maintenance of elimination. In this report, we review diagnostic and classification challenges for measles and rubella in near- and post-elimination settings.<\/jats:p>","DOI":"10.3390\/vaccines12060697","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T05:33:28Z","timestamp":1718948008000},"page":"697","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1077-9164","authenticated-orcid":false,"given":"Thomas D.","family":"Filardo","sequence":"first","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4711-5767","authenticated-orcid":false,"given":"Stephen N.","family":"Crooke","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Bankamp","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley","family":"Raines","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adria D.","family":"Mathis","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2499-4786","authenticated-orcid":false,"given":"Tatiana M.","family":"Lanzieri","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Suzanne","family":"Beard","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-8124","authenticated-orcid":false,"given":"Ludmila","family":"Perelygina","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0191-5467","authenticated-orcid":false,"given":"David E.","family":"Sugerman","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Rota","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"ref_1","unstructured":"WHO (2023, September 07). Global Vaccine Action Plan 2011\u20132020. Available online: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/strategies\/global-vaccine-action-plan#."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.15585\/mmwr.mm7246a3","article-title":"Progress Toward Measles Elimination\u2014Worldwide, 2000\u20132022","volume":"72","author":"Minta","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.15585\/mmwr.mm7308a2","article-title":"Progress Toward Rubella and Congenital Rubella Syndrome Elimination\u2014Worldwide, 2012\u20132022","volume":"73","author":"Ou","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_4","unstructured":"World Health Organization (2023, September 07). Immunization Agenda 2030: A Global Strategy to Leave No One Behind. Available online: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/strategies\/ia2030."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.15585\/mmwr.mm6517a3","article-title":"Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010\u20132015","volume":"65","author":"Mulders","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_6","unstructured":"World Health Organization (2024, April 15). Measles: Vaccine Preventable Diseases Surveillance Standards. Updated 14 October 2018. Available online: https:\/\/www.who.int\/publications\/m\/item\/vaccine-preventable-diseases-surveillance-standards-measles."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15585\/mmwr.mm7301a2","article-title":"Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger\u2014United States, 2024","volume":"73","author":"Wodi","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bolotin, S., Lim, G., Dang, V., Crowcroft, N., Gubbay, J., Mazzulli, T., and Schabas, R. (2017). The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009\u20132014. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181172"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/CVI.00211-16","article-title":"Immunoglobulin M for Acute Infection: True or False?","volume":"23","author":"Landry","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/jmv.20715","article-title":"Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection","volume":"78","author":"Navalpotro","year":"2006","journal-title":"J. Med. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1590\/S0037-86822010000300004","article-title":"Investigation of measles IgM-seropositive cases of febrile rash illnesses in the absence of documented measles virus transmission, State of S\u00e3o Paulo, Brazil, 2000\u20132004","volume":"43","author":"Ciccone","year":"2010","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_12","unstructured":"Centers for Disease Control and Prevention (2012). Notes from the field: False-positive measles test\u2014Maine, February 2012. MMWR Morb. Mortal. Wkly. Rep., 61, 396."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jpids\/pis133","article-title":"False-Positive Results for Immunoglobulin M Serologic Results: Explanations and Examples","volume":"2","author":"Woods","year":"2013","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e29141","DOI":"10.1002\/jmv.29141","article-title":"Differential diagnosis of fever and rash cases negative for measles and rubella to complement surveillance activities","volume":"95","author":"Fappani","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1086\/314513","article-title":"Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children","volume":"178","author":"Davidkin","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/jmv.21888","article-title":"Comparison of laboratory diagnostic methods for measles infection and identification of measles virus genotypes in Hong Kong","volume":"82","author":"Woo","year":"2010","journal-title":"J. Med. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1086\/377103","article-title":"Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands","volume":"188","author":"Kohl","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/JCM.39.1.375-376.2001","article-title":"Investigation of optimal specimen type and sampling time for detection of measles virus RNA during a measles epidemic","volume":"39","author":"Riddell","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2471\/BLT.07.046375","article-title":"Elimination of endemic measles transmission in Australia","volume":"87","author":"Heywood","year":"2009","journal-title":"Bull. World Health Organ."},{"key":"ref_20","first-page":"532","article-title":"Measles outbreak in the sanitary area of Guadalajara (Spain): Difficulty in microbiological diagnosis in the era of its elimination","volume":"40","year":"2022","journal-title":"Enferm. Infecc. Microbiol. Clin. (Engl. Ed.)"},{"key":"ref_21","unstructured":"Orenstein, W., Offit, P., Edwards, K.M., and Plotkin, S. (2023). Chapter 38\u2014Measles Vaccines. Plotkin\u2019s Vaccines, Elsevier. [8th ed.]."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e03161-20","DOI":"10.1128\/JCM.03161-20","article-title":"Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Measles Virus-Specific IgM Antibodies","volume":"59","author":"Hiebert","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/175.1.195","article-title":"Diagnosis of measles with an IgM capture EIA: The optimal timing of specimen collection after rash onset","volume":"175","author":"Helfand","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_24","first-page":"492","article-title":"Diagnostic algorithm for the confirmation of cases of measles and rubella in Mexico","volume":"155","year":"2019","journal-title":"Gac. Med. Mex."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jviromet.2011.04.001","article-title":"Diagnosis of recent primary rubella virus infections: Significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis","volume":"174","author":"Wandinger","year":"2011","journal-title":"J. Virol. Methods"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.325.7356.147","article-title":"Interpretation of rubella serology in pregnancy--pitfalls and problems","volume":"325","author":"Best","year":"2002","journal-title":"BMJ"},{"key":"ref_27","unstructured":"Orenstein, W., Offit, P., Edwards, K.M., and Plotkin, S. (2023). Chapter 54\u2014Rubella Vaccines. Plotkin\u2019s Vaccines, Elsevier. [8th ed.]."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105377","DOI":"10.1016\/j.jcv.2022.105377","article-title":"Shedding of rubella virus in postsymptomatic individuals; viral RNA load is a potential indicator to estimate candidate patients excreting infectious rubella virus","volume":"160","author":"Kanbayashi","year":"2023","journal-title":"J. Clin. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1093\/cid\/ciaa168","article-title":"Identifying Vaccine-associated Rash Illness Amidst a Large Measles Outbreak: Minnesota, 2017","volume":"71","author":"Martin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"McMahon, J., Mackay, I.M., and Lambert, S.B. (2019). Measles Vaccine Virus RNA in Children More Than 100 Days after Vaccination. Viruses, 11.","DOI":"10.1101\/548701"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/JCM.01879-16","article-title":"Rapid Identification of Measles Virus Vaccine Genotype by Real-Time PCR","volume":"55","author":"Roy","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_32","unstructured":"Association of Public Health Laboratories (2024, February 01). Measles Virus Genotype A RT-qPCR (MeVA RT-qPCR). Available online: https:\/\/www.aphl.org\/Materials\/VPD18_MeVA_Assay_CDC_Infosheet_032718.pdf."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Fappani, C., Gori, M., Canuti, M., Terraneo, M., Colzani, D., Tanzi, E., Amendola, A., and Bianchi, S. (2022). Breakthrough Infections: A Challenge towards Measles Elimination. Microorganisms, 10.","DOI":"10.3390\/microorganisms10081567"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00406-12","article-title":"Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings","volume":"19","author":"Mercader","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijid.2021.09.004","article-title":"Classification of measles breakthrough cases in an elimination setting using a comprehensive algorithm of laboratory results: Why sensitive and specific IgM assays are important","volume":"112","author":"Mercader","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_36","unstructured":"Centers for Disease Control and Prevention (2024, February 01). Epidemiology and prevention of vaccine-preventable diseases: Measles [Chapter 13], The Pink Book, Available online: https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/meas.html."},{"key":"ref_37","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: Summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nrmicro1550","article-title":"Global measles elimination","volume":"4","author":"Moss","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jama.2017.9984","article-title":"Incidence of Measles in the United States, 2001\u20132015","volume":"318","author":"Clemmons","year":"2017","journal-title":"JAMA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/CVI.00268-16","article-title":"High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases","volume":"23","author":"Sowers","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.15585\/mmwr.mm6826a3","article-title":"Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016\u20132018","volume":"68","author":"Brown","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_42","unstructured":"World Health Organization (2024, February 01). Weekly Epidemiological Record (WER), 30 September 2022, Vol. 97, No. 39. Available online: https:\/\/reliefweb.int\/report\/world\/weekly-epidemiological-record-wer-30-september-2022-vol-97-no-39-2022-pp-481-492-enfr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1016\/S2468-2667(23)00130-5","article-title":"Measles virus transmission patterns and public health responses during Operation Allies Welcome: A descriptive epidemiological study","volume":"8","author":"Masters","year":"2023","journal-title":"Lancet Public Health"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/infdis\/jiv271","article-title":"Whole-Genome Sequencing of Measles Virus Genotypes H1 and D8 During Outbreaks of Infection Following the 2010 Olympic Winter Games Reveals Viral Transmission Routes","volume":"212","author":"Gardy","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.coviro.2020.05.007","article-title":"Rapid diagnostic tests to address challenges for global measles surveillance","volume":"41","author":"Brown","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/INF.0000000000004175","article-title":"Clinical and Laboratory Diagnosis of Exanthems Among Japanese Children Younger Than 6 Years Old in the Post-Measles-Rubella Vaccine Era","volume":"43","author":"Yasuda","year":"2023","journal-title":"Pediatr. Infect. Dis. J."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/6\/697\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:01:59Z","timestamp":1760108519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/6\/697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["vaccines12060697"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12060697","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]}}}